Trial search - ClinicalTrials.eu

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment

Recruiting

3 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
Investigated Drugs:
- [4-(METHYL-1H-PYRAZOL-4-YL)-BENZYL]-(6[7-(3-PYRROLIDIN-1-YL-PROPOXY)-IMIDAZO[1,2-A]PYRIDIN-3-YL]-PYRIMIDIN-4-YL]-AMINE
- Sunitinib
+4
Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

Recruiting

2 1 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
Investigated Drugs:
Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

Not yet recruiting

4 1 1
Investigated Diseases:
Investigated Drugs:
- (S)-2,2′,2”-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Not recruiting

4 1 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
- Embolism venous
Investigated Drugs:
- Abelacimab
- Dalteparin Sodium
+6
Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

Not recruiting

1 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
- Colorectal cancer metastatic
Investigated Drugs:
- 4-[1-[[6-[[4-(Trifluoromethyl)Phenyl]Methyl]-6-Azaspiro[2.5]Octane-7-Carbonyl]Amino]Cyclopropyl]Benzoic Acid
- Balstilimab
Study of Retifanlimab, Capecitabine, and Oxaliplatin for First-Line Treatment in Patients with Metastatic Esophagogastric Cancer

Not recruiting

2 1 1
Investigated Diseases:
- Gastrointestinal cancer metastatic
- Gastrooesophageal cancer
Investigated Drugs:
- Retifanlimab
Study of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy

Not recruiting

3 1 1
Investigated Diseases:
- Colorectal adenocarcinoma
- Gastrointestinal cancer metastatic
Investigated Drugs:
- Romiplostim
+2

Opportunities for Healthy Volunteers

Matched clinical trials

Study of GSK6042981 compared to sunitinib for patients with gastrointestinal stromal tumors that spread or cannot be removed after imatinib treatment

Chemotherapy Dose Adjustment for Gastrointestinal Cancer Patients with DPD Deficiency Using Fluorouracil, Capecitabine, and Oxaliplatin

Study on 68Ga-FAPI-46 PET Imaging for Patients with Gastrointestinal Cancers

Study on Abelacimab and Dalteparin for Preventing Blood Clots in Patients with Gastrointestinal or Genitourinary Cancer

Study on the Safety and Efficacy of CR6086 and Balstilimab for Patients with Pretreated Metastatic Colorectal and Other GI Cancers

Study of Retifanlimab, Capecitabine, and Oxaliplatin for First-Line Treatment in Patients with Metastatic Esophagogastric Cancer

Study of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy

We use cookies